BIOLOGÍA CELULAR Y PATOLOGÍA
Departamento
ATANASIO
PANDIELLA ALONSO
Investigador
Publicaciones en las que colabora con ATANASIO PANDIELLA ALONSO (8)
2023
-
An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer
Journal of experimental & clinical cancer research : CR, Vol. 42, Núm. 1, pp. 200
-
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257
2019
-
MEK5 promotes lung adenocarcinoma
The European respiratory journal
2014
-
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer
Oncogene, Vol. 33, Núm. 2, pp. 148-156
2012
-
Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects
PLoS ONE, Vol. 7, Núm. 4
2009
2007
-
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663
1997
-
Expression of the β-isoforms of Na,K-ATPase in the renal cortex of rats
Experimental Nephrology, Vol. 5, Núm. 1, pp. 82-87